Lactose Intolerance Treatment Global Market Report 2024

The lactose intolerance treatment market size has grown strongly in recent years. It will grow from $30.52 billion in 2023 to $32.78 billion in 2024 at a compound annual growth rate (CAGR) of 7.4%. The growth observed in the historical period can be attributed to several factors, including heightened awareness, evolving dietary patterns, a global increase in lactose intolerance cases, the expansion of healthcare infrastructure, consumer preferences shifting towards natural and alternative products, and government investments.

The lactose intolerance treatment market size is expected to see strong growth in the next few years. It will grow to $43.59 billion in 2028 at a compound annual growth rate (CAGR) of 7.4%. The anticipated growth in the forecast period can be attributed to ongoing research and development efforts, a rise in incidence rates, the adoption of personalized medicine approaches, an increase in healthcare expenditure, the globalization of dietary habits, and a shift towards patient-centric healthcare. Key trends expected in the forecast period include a growing demand for dairy alternatives, technological advancements in diagnostic tools, the development of enzyme supplements, nutraceuticals, and functional foods, increased global awareness through education initiatives, and an expansion in emerging markets.

The anticipated growth of the lactose intolerance treatment market is driven by the increasing incidences of small intestine diseases. These diseases affect the digestive system, leading to persistent inflammation in the gastrointestinal tract. Lactose intolerance treatment is utilized to address small intestine disorders, containing lactose that is broken down by the enzyme lactase in the small intestine into simpler sugars such as glucose and galactose. For example, a report from the United European Gastroenterology (UEG) in October 2022 highlighted that over 300 million people in Europe suffer from digestive illnesses, translating to potential costs of $20 billion in 2021. The increasing prevalence of small intestine diseases is, therefore, a significant factor propelling the growth of the lactose intolerance treatment market.

The expansion of the lactose intolerant population is expected to contribute to the growth of the lactose intolerance treatment market. Lactose intolerance, characterized by the inability to fully digest lactose found in milk and dairy products, has a global prevalence of approximately 65%, according to the National Institutes of Health (NIH). This condition is prevalent among specific demographic groups, such as 50% to 80% of South Americans and 100% of American Indians. The rising population of lactose intolerant individuals is driving the demand for effective lactose intolerance treatment, making it a key factor influencing market growth.

The lactose intolerance treatment market is further supported by the increasing global population. The expansion of the world population, coupled with evolving dietary patterns, has led to a higher number of individuals experiencing lactose intolerance. This demographic shift, along with increased awareness of lactose intolerance, is expected to stimulate innovation and investment in therapeutic solutions. As per the United Nations projections, the global population is estimated to reach 8.5 billion in 2030 and further increase to 9.7 billion in 2050. This growth in population will consequently drive the demand for lactose intolerance treatment in the market.

Technological advancements are a prominent trend in the lactose intolerance treatment market. Major companies are actively developing technological solutions to enhance their market positions. For instance, Nestlé introduced a versatile and cost-effective sugar reduction technology in July 2023, applicable across different product categories. This technology not only reduces sugar but can also be utilized to produce low lactose and skimmed milk-based products, contributing to the technological advancements in the lactose intolerance treatment market.

Innovative products, such as animal-free creams, are being introduced by major companies in the lactose intolerance treatment market to sustain their positions. Animal-free cream cheese, a plant-based alternative for individuals with lactose intolerance, has been launched by Modern Kitchen in February 2022. Utilizing precision fermentation technology, this dairy-free product is made from real dairy but is lactose-free, hormone-free, and cholesterol-free. This innovation aligns with the market's focus on introducing alternatives to traditional dairy products to meet the needs of lactose intolerant consumers.

Major companies operating in the lactose intolerance treatment market report are Johnson & Johnson Services Inc., Abbott Laboratories Inc., Macleods Pharmaceuticals Limited, Nature's Way Brands LLC, Profarma, Ganeden Inc., Deerland Probiotics & Enzymes Inc., Novozymes A/S, Cargill Incorporated, Dean Foods Company, Lupin Pharmaceuticals Inc., Nestlé S.A., Alembic Pharmaceuticals Limited, Glenmark Pharmaceuticals Limited, Intas Pharmaceuticals Ltd., Jubilant Life Sciences Limited, Wockhardt Ltd., Alkem Laboratories Limited, Teva Pharmaceutical Industries Ltd., Mylan N.V., Dr. Reddy's Laboratories Ltd., Torrent Pharmaceuticals Ltd., Amgen Inc., DuPont Nutrition & Biosciences Inc., Kerry Group plc, Koninklijke DSM N.V., Solvay S.A., Chr. Hansen Holding A/S, Bio-Cat Inc., Solgar Inc.

North America was the largest region in the lactose intolerance treatment market in 2023. The regions covered in the lactose intolerance treatment market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the lactose intolerance treatment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Various methods are employed in lactose intolerance treatment, including food supplements, enzyme lactase supplements, probiotics, and others. Food supplements are designed to compensate for nutritional deficiencies, ensure the adequate intake of specific nutrients, or support particular physiological functions. The types of intolerance covered include primary lactose intolerance, secondary lactose intolerance, congenital lactose intolerance, and developmental lactose intolerance, with administration through oral and injectable methods. These treatments are utilized by hospitals, homecare services, specialty clinics, and other end users.

The lactose intolerance treatment market research report is one of a series of new reports that provides lactose intolerance treatment market statistics, including lactose intolerance treatment industry global market size, regional shares, competitors with lactose intolerance treatment market share, detailed lactose intolerance treatment market segments, market trends, and opportunities, and any further data you may need to thrive in the lactose intolerance treatment industry. This lactose intolerance treatment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.